Myriad Receives FDA Approval of myChoice CDx® as Companion Diagnostic for Lynparza™ (olaparib) In Patients with Advanced Ovarian Cancer

    NEXT STORY
    OpGen CEO and Chairman of the Board Issue Letters to Stockholders
    PREV STORY
    Amryt Pharma Plc – Full Year 2019 RESULTS
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    MorphoSys to Present Clinical Trial Data on Proprietary Programs at Upcoming ASCO Annual Meeting 2016

    MARTINSRIED / MUNICH, Germany, May 19, 2016 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; ...

    author_avatar
    NASDAQ Market News

    Generex Announces That the Process to Retire 20,375,900 GNBT “Pool Shares” is Complete

    author_avatar
    NASDAQ Market News

    Five Prime Therapeutics to Announce Second Quarter 2017 Financial Results and Host Conference Call on August 8

    SOUTH SAN FRANCISCO, Calif., July 26, 2017 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. ...

    author_avatar
    NASDAQ Market News